- Home
- AGIG vs ANIX Comparison
AGIG vs ANIX Comparison
Compare AGIG & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AGIG | ANIX |
|---|---|---|
| Founded | N/A | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.3M | 104.0M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | AGIG | ANIX |
|---|---|---|
| Price | $1.34 | $2.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.67 |
| AVG Volume (30 Days) | ★ 848.6K | 93.4K |
| Earning Date | 05-08-2026 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 12.82 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $210,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.34 | $2.33 |
| 52 Week High | $5.31 | $5.46 |
Technical Indicators
Market Signals| Indicator | AGIG | ANIX |
|---|---|---|
| Relative Strength Index (RSI) | 35.11 | 49.26 |
| Support Level | N/A | N/A |
| Resistance Level | $3.97 | $3.10 |
| Average True Range (ATR) | 0.14 | 0.20 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 0.00 | 64.00 |
Price Performance
Historical ComparisonAbout AGIG Abundia Global Impact Group Inc. Common stock
Abundia Global Impact Group Inc is a technology solutions company that operates in the recycling and renewable energy, environmental change, fuels and chemicals sectors. The company focuses on using waste products to decarbonize the energy, fuels and chemicals sector by providing renewable or recycled alternatives.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.